Why did ABT.SW stock drop so sharply intraday?

The intraday drop to CHF88.00 appears driven by sector weakness, technical selling and a cautious company rating from some providers. No single Abbott press release explained the move at time of writing.

What are key support and resistance levels for ABT.SW stock?

Immediate support is near the 52-week low **CHF85.00**. Resistance sits at the 50-day average **CHF95.35** and the 200-day average **CHF101.01**; reclaiming these levels would ease short-term risk.

What is Meyka AI’s short-term forecast for ABT.SW stock?

Meyka AI's forecast model projects a 12-month target of **CHF100.11**, implying about **13.76%** upside from today’s **CHF88.00**. Forecasts are model-based projections and not guarantees.

When is Abbott’s next earnings and how could it affect ABT.SW stock?

Abbott’s next earnings announcement is scheduled for 2026-04-15. Earnings beats or guidance raises could trigger a rebound; misses would likely extend downside pressure.

CH Stocks

Intraday drop: ABT.SW stock down 12.00% on SIX as price hits CHF88.00, what analysts watch next

ByDanny Kontos March 4, 2026March 4, 2026

ABT.SW stock opened lower and is trading at CHF88.00 intraday on SIX after a sharp one-day decline of -12.00% from a previous close of CHF100.00. The move makes Abbott Laboratories one of the top intraday losers in the Swiss session and comes on very light volume (10.00 shares) with relative volume at 11.25. Investors are watching valuation gaps—P/E 30.45 and EPS 2.89—against healthcare peers and the stock’s technical oversold signals. We summarise why ABT.SW stock moved today and what to watch next